data_6hir_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6hir _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.436 -0.579 . . . . 3.15 109.436 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.6 t -131.24 141.98 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 119.842 -0.743 . . . . 1.97 109.849 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -95.2 -178.63 4.52 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.512 -0.875 . . . . 1.24 110.382 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.431 ' OG1' ' OE2' ' A' ' 47' ' ' GLU . 51.2 p -91.27 -171.59 3.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.472 -0.891 . . . . 1.69 110.266 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.55 168.25 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.346 -0.941 . . . . 1.23 110.109 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -92.92 167.28 11.93 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.362 -0.935 . . . . 1.11 110.684 -179.655 -98.949 85.297 -96.044 104.136 2.018 104.367 -169.084 85.241 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.0 -11.45 0.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.79 -0.764 . . . . 2.02 109.766 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -142.28 172.03 13.25 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.754 -0.778 . . . . 2.21 109.546 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.93 135.66 35.03 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.29 -0.964 . . . . 0.95 110.181 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 114.13 -19.4 17.74 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.888 -1.149 . . . . 1.06 110.586 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -54.21 -171.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.037 -1.065 . . . . 1.87 109.425 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 22' ' ' CYS . 1.5 m-20 -149.07 -69.72 0.21 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.662 -1.215 . . . . 1.6 110.872 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.9 mt -76.89 87.51 3.46 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.83 -1.148 . . . . 1.22 109.853 -179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.8 p -160.35 -150.93 0.23 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.418 -0.81 . . . . 0.39 109.655 179.982 85.241 -169.084 -96.044 104.367 2.018 104.136 85.297 -98.949 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.564 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 15.3 mt -128.55 100.69 5.85 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.915 -0.714 . . . . 1.18 109.305 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 m -95.38 -57.72 2.32 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.469 -0.892 . . . . 1.13 110.634 -179.39 -45.348 172.832 129.859 104.442 2.017 104.184 -151.696 -110.634 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -84.47 97.31 9.46 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.101 -1.04 . . . . 2.17 109.922 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.76 -101.77 0.2 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.532 -1.318 . . . . 1.17 110.664 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.408 ' O ' ' OG ' ' A' ' 19' ' ' SER . 0.2 OUTLIER -124.74 11.54 8.46 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.887 -0.725 . . . . 1.19 110.392 -179.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -83.69 146.66 28.1 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.223 -0.991 . . . . 1.69 109.894 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -89.54 128.25 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.235 -0.986 . . . . 1.18 110.88 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 12' ' ' ASN . 1.3 m -133.48 105.24 6.8 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.318 -0.855 . . . . 1.5 108.782 179.326 -94.384 -174.438 91.266 103.75 2.022 104.177 -145.171 -46.203 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -153.91 -108.44 0.33 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 118.022 -2.037 . . . . 1.85 112.935 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' GLY . 5.4 tt0 -37.63 132.43 0.87 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.259 0.552 . . . . 3.04 111.514 -178.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.476 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 91.18 -13.48 66.19 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.59 -1.291 . . . . 1.47 110.677 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.476 ' ND2' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -148.16 -174.84 4.68 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.942 -1.103 . . . . 1.81 111.123 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.4 ttpp -129.87 143.79 50.98 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 115.319 -0.855 . . . . 1.65 108.932 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.73 141.52 48.1 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.381 -0.928 . . . . 0.92 111.458 -179.057 -110.634 -151.696 129.859 104.184 2.017 104.442 172.832 -45.348 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 mm -123.73 134.57 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-N 115.074 -0.966 . . . . 1.25 108.568 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.43 ' O ' ' C ' ' A' ' 31' ' ' GLY . 12.1 mt -79.01 -168.89 1.6 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.809 -1.156 . . . . 1.44 110.465 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 30' ' ' LEU . . . -32.74 108.33 0.03 OUTLIER Glycine 0 N--CA 1.497 2.738 0 CA-C-N 115.49 -0.777 . . . . 2.25 112.215 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -67.77 -91.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.563 -0.855 . . . . 4.82 108.979 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.435 ' C ' ' H ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -106.04 81.61 1.66 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.476 -0.935 . . . . 7.21 108.476 178.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.36 8.58 13.25 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.068 -1.613 . . . . 5.41 109.068 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 33' ' ' ASP . 8.0 mt-10 -94.65 -165.84 1.38 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.774 -0.77 . . . . 4.61 110.632 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -92.94 -166.39 1.52 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.733 -0.787 . . . . 4.26 110.722 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -84.07 166.27 17.84 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.857 -0.737 . . . . 1.96 110.688 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -148.35 144.33 27.46 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.707 -0.797 . . . . 2.0 110.224 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.6 m -97.87 97.9 9.36 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.485 -0.886 . . . . 0.99 110.356 179.962 -46.203 -145.171 91.266 104.177 2.022 103.75 -174.438 -94.384 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.5 p -105.74 135.31 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.597 -0.841 . . . . 1.24 110.154 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 t -60.34 140.05 57.33 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.298 -0.961 . . . . 1.34 110.363 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.75 -147.46 11.68 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.448 -1.358 . . . . 1.17 110.52 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -124.58 110.79 14.87 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.986 -0.686 . . . . 2.81 110.23 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.43 157.99 21.03 Favored Glycine 0 N--CA 1.497 2.763 0 C-N-CA 119.815 -1.183 . . . . 1.26 110.596 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 146.9 32.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 119.519 -0.873 . . . . 1.45 109.072 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.95 -174.15 0.03 OUTLIER 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 120.812 1.008 . . . . 0.93 110.607 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.431 ' OE2' ' OG1' ' A' ' 4' ' ' THR . 0.6 OUTLIER -108.06 101.68 42.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 C-N-CA 119.729 -0.788 . . . . 2.29 109.388 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.38 -168.88 0.05 OUTLIER 'Trans proline' 0 C--O 1.218 -0.506 0 C-N-CA 121.016 1.144 . . . . 3.56 111.19 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 116.34 -1.79 . . . . 4.5 110.03 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.436 -0.579 . . . . 2.73 109.436 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.6 t -131.24 141.98 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 119.842 -0.743 . . . . 1.46 109.849 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -95.2 -178.63 4.52 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.512 -0.875 . . . . 0.71 110.382 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.404 ' OG1' ' OE2' ' A' ' 47' ' ' GLU . 51.2 p -91.27 -171.59 3.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.472 -0.891 . . . . 1.2 110.266 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -89.55 168.25 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.346 -0.941 . . . . 1.23 110.109 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -92.92 167.28 11.93 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.362 -0.935 . . . . 1.11 110.684 -179.655 -98.949 85.297 -96.044 104.136 2.018 104.367 -169.084 85.241 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.0 -11.45 0.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.79 -0.764 . . . . 1.41 109.766 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 30' ' ' LEU . 24.3 mt-10 -142.28 172.03 13.25 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.754 -0.778 . . . . 2.21 109.546 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.93 135.66 35.03 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.29 -0.964 . . . . 0.75 110.181 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 114.13 -19.4 17.74 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.888 -1.149 . . . . 0.55 110.586 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -54.21 -171.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.037 -1.065 . . . . 1.87 109.425 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 22' ' ' CYS . 1.5 m-20 -149.07 -69.72 0.21 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.662 -1.215 . . . . 1.6 110.872 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' H ' ' HA ' ' A' ' 46' ' ' PRO . 86.9 mt -76.89 87.51 3.46 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.83 -1.148 . . . . 0.51 109.853 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.8 p -160.35 -150.93 0.23 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.418 -0.81 . . . . 0.39 109.655 179.982 85.241 -169.084 -96.044 104.367 2.018 104.136 85.297 -98.949 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.564 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 15.3 mt -128.55 100.69 5.85 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.915 -0.714 . . . . 0.6 109.305 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 m -95.38 -57.72 2.32 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.469 -0.892 . . . . 1.13 110.634 -179.39 -45.348 172.832 129.859 104.442 2.017 104.184 -151.696 -110.634 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -84.47 97.31 9.46 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.101 -1.04 . . . . 2.17 109.922 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.76 -101.77 0.2 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.532 -1.318 . . . . 0.8 110.664 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.74 11.54 8.46 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.887 -0.725 . . . . 0.79 110.392 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -83.69 146.66 28.1 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.223 -0.991 . . . . 1.39 109.894 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -89.54 128.25 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.235 -0.986 . . . . 0.53 110.88 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 12' ' ' ASN . 1.3 m -133.48 105.24 6.8 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.318 -0.855 . . . . 1.5 108.782 179.326 -94.384 -174.438 91.266 103.75 2.022 104.177 -145.171 -46.203 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -153.91 -108.44 0.33 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 118.022 -2.037 . . . . 1.24 112.935 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' GLY . 5.4 tt0 -37.63 132.43 0.87 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.259 0.552 . . . . 2.78 111.514 -178.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 91.18 -13.48 66.19 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.59 -1.291 . . . . 0.99 110.677 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.16 -174.84 4.68 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.942 -1.103 . . . . 1.67 111.123 -179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.4 ttpp -129.87 143.79 50.98 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 115.319 -0.855 . . . . 1.04 108.932 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.73 141.52 48.1 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.381 -0.928 . . . . 0.92 111.458 -179.057 -110.634 -151.696 129.859 104.184 2.017 104.442 172.832 -45.348 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 mm -123.73 134.57 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-N 115.074 -0.966 . . . . 0.62 108.568 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.437 HD23 ' CG ' ' A' ' 37' ' ' ASN . 12.1 mt -79.01 -168.89 1.6 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.809 -1.156 . . . . 0.9 110.465 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 30' ' ' LEU . . . -32.74 108.33 0.03 OUTLIER Glycine 0 N--CA 1.497 2.738 0 CA-C-N 115.49 -0.777 . . . . 2.25 112.215 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -67.77 -91.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.563 -0.855 . . . . 4.57 108.979 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -106.04 81.61 1.66 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.476 -0.935 . . . . 7.21 108.476 178.579 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.36 8.58 13.25 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.068 -1.613 . . . . 4.9 109.068 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 33' ' ' ASP . 8.0 mt-10 -94.65 -165.84 1.38 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.774 -0.77 . . . . 4.61 110.632 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -92.94 -166.39 1.52 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.733 -0.787 . . . . 3.89 110.722 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -84.07 166.27 17.84 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.857 -0.737 . . . . 1.59 110.688 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -148.35 144.33 27.46 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.707 -0.797 . . . . 1.48 110.224 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.6 m -97.87 97.9 9.36 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.485 -0.886 . . . . 0.99 110.356 179.962 -46.203 -145.171 91.266 104.177 2.022 103.75 -174.438 -94.384 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.5 p -105.74 135.31 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.597 -0.841 . . . . 0.61 110.154 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 t -60.34 140.05 57.33 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.298 -0.961 . . . . 0.7 110.363 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.75 -147.46 11.68 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.448 -1.358 . . . . 0.97 110.52 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -124.58 110.79 14.87 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.986 -0.686 . . . . 2.81 110.23 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.43 157.99 21.03 Favored Glycine 0 N--CA 1.497 2.763 0 C-N-CA 119.815 -1.183 . . . . 0.74 110.596 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 146.9 32.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 119.519 -0.873 . . . . 0.92 109.072 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HA ' ' H ' ' A' ' 13' ' ' LEU . 4.3 Cg_exo -54.95 -174.15 0.03 OUTLIER 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 120.812 1.008 . . . . 0.88 110.607 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' OE2' ' OG1' ' A' ' 4' ' ' THR . 0.6 OUTLIER -108.06 101.68 42.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 C-N-CA 119.729 -0.788 . . . . 2.29 109.388 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.38 -168.88 0.05 OUTLIER 'Trans proline' 0 C--O 1.218 -0.506 0 C-N-CA 121.016 1.144 . . . . 2.91 111.19 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 116.34 -1.79 . . . . 4.4 110.03 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.436 -0.579 . . . . 2.73 109.436 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.6 t -131.24 141.98 44.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 119.842 -0.743 . . . . 1.46 109.849 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -95.2 -178.63 4.52 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.512 -0.875 . . . . 0.71 110.382 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.404 ' OG1' ' OE2' ' A' ' 47' ' ' GLU . 51.2 p -91.27 -171.59 3.01 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.472 -0.891 . . . . 1.2 110.266 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.502 ' OD1' HD12 ' A' ' 15' ' ' LEU . 0.8 OUTLIER -89.55 168.25 12.32 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.346 -0.941 . . . . 1.23 110.109 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.2 m -92.92 167.28 11.93 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 119.362 -0.935 . . . . 1.11 110.684 -179.655 -98.949 85.297 -96.044 104.136 2.018 104.367 -169.084 85.241 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.0 -11.45 0.97 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.79 -0.764 . . . . 1.41 109.766 179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.436 ' C ' HD12 ' A' ' 30' ' ' LEU . 24.3 mt-10 -142.28 172.03 13.25 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.754 -0.778 . . . . 2.21 109.546 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.93 135.66 35.03 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.29 -0.964 . . . . 0.75 110.181 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' O ' ' O ' ' A' ' 11' ' ' GLN . . . 114.13 -19.4 17.74 Favored Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.888 -1.149 . . . . 0.55 110.586 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.428 ' O ' ' O ' ' A' ' 10' ' ' GLY . 0.1 OUTLIER -54.21 -171.3 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.037 -1.065 . . . . 1.87 109.425 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.427 ' O ' ' O ' ' A' ' 22' ' ' CYS . 1.5 m-20 -149.07 -69.72 0.21 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.662 -1.215 . . . . 1.6 110.872 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.436 ' H ' ' HA ' ' A' ' 46' ' ' PRO . 86.9 mt -76.89 87.51 3.46 Favored 'General case' 0 N--CA 1.496 1.866 0 C-N-CA 118.83 -1.148 . . . . 0.51 109.853 -179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.564 ' SG ' ' N ' ' A' ' 15' ' ' LEU . 1.8 p -160.35 -150.93 0.23 Allowed 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.418 -0.81 . . . . 0.39 109.655 179.982 85.241 -169.084 -96.044 104.367 2.018 104.136 85.297 -98.949 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.564 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 15.3 mt -128.55 100.69 5.85 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 119.915 -0.714 . . . . 0.6 109.305 179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.4 m -95.38 -57.72 2.32 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.469 -0.892 . . . . 1.13 110.634 -179.39 -45.348 172.832 129.859 104.442 2.017 104.184 -151.696 -110.634 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -84.47 97.31 9.46 Favored 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.101 -1.04 . . . . 2.17 109.922 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 57.76 -101.77 0.2 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.532 -1.318 . . . . 0.8 110.664 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.74 11.54 8.46 Favored 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.887 -0.725 . . . . 0.79 110.392 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -83.69 146.66 28.1 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 119.223 -0.991 . . . . 1.39 109.894 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.3 t -89.54 128.25 41.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 119.235 -0.986 . . . . 0.53 110.88 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.427 ' O ' ' O ' ' A' ' 12' ' ' ASN . 1.3 m -133.48 105.24 6.8 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 115.318 -0.855 . . . . 1.5 108.782 179.326 -94.384 -174.438 91.266 103.75 2.022 104.177 -145.171 -46.203 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' O ' ' C ' ' A' ' 24' ' ' GLN . . . -153.91 -108.44 0.33 Allowed Glycine 0 N--CA 1.49 2.268 0 C-N-CA 118.022 -2.037 . . . . 1.24 112.935 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.402 ' C ' ' O ' ' A' ' 23' ' ' GLY . 5.4 tt0 -37.63 132.43 0.87 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 121.259 0.552 . . . . 2.78 111.514 -178.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.476 ' C ' ' ND2' ' A' ' 26' ' ' ASN . . . 91.18 -13.48 66.19 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.59 -1.291 . . . . 0.99 110.677 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.476 ' ND2' ' C ' ' A' ' 25' ' ' GLY . 0.0 OUTLIER -148.16 -174.84 4.68 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.942 -1.103 . . . . 1.67 111.123 -179.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' O ' ' O ' ' A' ' 40' ' ' VAL . 8.4 ttpp -129.87 143.79 50.98 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 115.319 -0.855 . . . . 1.04 108.932 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -116.73 141.52 48.1 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 119.381 -0.928 . . . . 0.92 111.458 -179.057 -110.634 -151.696 129.859 104.184 2.017 104.442 172.832 -45.348 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 mm -123.73 134.57 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-N 115.074 -0.966 . . . . 0.62 108.568 179.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.437 HD23 ' CG ' ' A' ' 37' ' ' ASN . 12.1 mt -79.01 -168.89 1.6 Allowed 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.809 -1.156 . . . . 0.9 110.465 -179.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 30' ' ' LEU . . . -32.74 108.33 0.03 OUTLIER Glycine 0 N--CA 1.497 2.738 0 CA-C-N 115.49 -0.777 . . . . 2.25 112.215 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 m -67.77 -91.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.563 -0.855 . . . . 4.57 108.979 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 35' ' ' GLU . 0.2 OUTLIER -106.04 81.61 1.66 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.476 -0.935 . . . . 7.21 108.476 178.579 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 61.36 8.58 13.25 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.068 -1.613 . . . . 4.9 109.068 -178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 33' ' ' ASP . 8.0 mt-10 -94.65 -165.84 1.38 Allowed 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.774 -0.77 . . . . 4.61 110.632 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.2 mttm -92.94 -166.39 1.52 Allowed 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.733 -0.787 . . . . 3.89 110.722 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.496 ' OD1' ' N ' ' A' ' 37' ' ' ASN . 0.2 OUTLIER -84.07 166.27 17.84 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.857 -0.737 . . . . 1.59 110.688 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -148.35 144.33 27.46 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.707 -0.797 . . . . 1.48 110.224 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 13.6 m -97.87 97.9 9.36 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 119.485 -0.886 . . . . 0.99 110.356 179.962 -46.203 -145.171 91.266 104.177 2.022 103.75 -174.438 -94.384 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.43 ' O ' ' O ' ' A' ' 27' ' ' LYS . 1.5 p -105.74 135.31 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 C-N-CA 119.597 -0.841 . . . . 0.61 110.154 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.0 t -60.34 140.05 57.33 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 119.298 -0.961 . . . . 0.7 110.363 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.75 -147.46 11.68 Favored Glycine 0 N--CA 1.491 2.347 0 C-N-CA 119.448 -1.358 . . . . 0.97 110.52 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -124.58 110.79 14.87 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 119.986 -0.686 . . . . 2.81 110.23 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -127.43 157.99 21.03 Favored Glycine 0 N--CA 1.497 2.763 0 C-N-CA 119.815 -1.183 . . . . 0.74 110.596 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.75 146.9 32.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 C-N-CA 119.519 -0.873 . . . . 0.92 109.072 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.436 ' HA ' ' H ' ' A' ' 13' ' ' LEU . 4.3 Cg_exo -54.95 -174.15 0.03 OUTLIER 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 120.812 1.008 . . . . 0.88 110.607 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' OE2' ' OG1' ' A' ' 4' ' ' THR . 0.6 OUTLIER -108.06 101.68 42.49 Favored Pre-proline 0 N--CA 1.496 1.829 0 C-N-CA 119.729 -0.788 . . . . 2.29 109.388 179.589 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -60.38 -168.88 0.05 OUTLIER 'Trans proline' 0 C--O 1.218 -0.506 0 C-N-CA 121.016 1.144 . . . . 2.91 111.19 -178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.493 1.714 0 CA-C-O 116.34 -1.79 . . . . 4.4 110.03 -179.596 . . . . . . . . 1 1 . 1 stop_ save_